Ribosomal protein L8 pseudogene 3 (RPL8P3)

Ribosomal protein L8 pseudogene 3 (RPL8P3) is classified as a processed pseudogene, meaning it is a non-functional genomic sequence derived from the ribosomal protein L8 gene[5][10][12][15][16]. It does not encode a functional protein and is not associated with any known molecular, biological, or disease functions. Pseudogenes like RPL8P3 are widespread throughout the genome and are formed primarily via retrotransposition of the parent gene, but lack essential features required for gene expression and protein synthesis[2][5][15]. RPL8P3 is not considered a therapeutic target or biological marker, and there is no evidence of medically actionable relevance, disease association, or drug interactions. Ribosomal protein L8 (RPL8), the functional parent gene, has documented roles in ribosome structure and function, and in some cases, cancer biology[1][7][14], but RPL8P3 itself does not share these characteristics because it is a pseudogene. There is nothing pharmacologically actionable, nor is there any biological activity attributed to RPL8P3. The presence of "pseudogene" in the name, as well as reference sequence annotations and gene ontology databases, confirm its non-functional status and absence of therapeutic relevance[5][10][12][15][16].

Other names

RPL8P3RPL8_1_413